Form 8-K - Current report:
SEC Accession No. 0000950170-23-002786
Filing Date
2023-02-14
Accepted
2023-02-14 16:15:41
Documents
14
Period of Report
2023-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20230214.htm   iXBRL 8-K 64316
2 EX-99.1 adpt-ex99_1.htm EX-99 388448
3 GRAPHIC img119828894_0.jpg GRAPHIC 7887
  Complete submission text file 0000950170-23-002786.txt   602008

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adpt-20230214.xsd EX-101.SCH 2495
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adpt-20230214_pre.xml EX-101.PRE 10687
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adpt-20230214_lab.xml EX-101.LAB 17004
8 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20230214_htm.xml XML 4542
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 23629495
SIC: 2836 Biological Products, (No Diagnostic Substances)